VHT
HealthcareVanguard Health Care Index Fund ETF Shares
Vanguard · Tracks MSCI US Investable Market Health Care 25/50 Index · Inception Jan 26, 2004
Trailing returns
through Nov 10, 2026- 1 year
- +20.3%
- 3 year
- +15.2%
- annualized
- 5 year
- +8.6%
- annualized
Price return from month-end closes, distributions reinvested at month end. Excludes trading costs, bid-ask spreads and taxes. Past performance says nothing about future returns and is not part of the composite score — see the methodology for what the score does measure.
Composite score
Based on a 0.090% expense ratio.
Based on $23.73B in net assets for the whole fund, all 2 share classes. Our sources don't report the ETF class alone.
Top-10 holdings represent 51.7% of net assets.
Healthcare base · ETF wrapper · 1.32% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.2).
Look through VHT, or compare the fee
Tool · Look-through
Underlying holdings, with other funds added
Add tickers and weights; N-PORT positions are summed across the basket.
Tool · Cost
Compare VHT's fee against another fund
Compounds the 0.090% expense ratio against a peer over decades.
Tool · Overlap
Compare VHT's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Healthcare funds.
Tool · TLH
Find a tax-loss harvesting partner for VHT
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Asset location for VHT across account types
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Eli Lilly & Co | 12.87% |
| 2 | Johnson & Johnson | 8.75% |
| 3 | AbbVie Inc | 6.28% |
| 4 | Merck & Co Inc | 5.06% |
| 5 | UnitedHealth Group Inc | 4.90% |
| 6 | Amgen Inc | 3.21% |
| 7 | Thermo Fisher Scientific Inc | 3.18% |
| 8 | Abbott Laboratories | 2.66% |
| 9 | Gilead Sciences Inc | 2.52% |
| 10 | Pfizer Inc | 2.24% |
Compare VHT with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open VHT at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.